Skip to Content
You are currently on the new version of our website. Access the old version .
LifeLife
  • Systematic Review
  • Open Access

31 March 2026

16 Pages

Perioperative Probiotic Supplementation to Reduce Postoperative Infection and Inflammation in Children and Neonates Undergoing Gastrointestinal Surgery: A Systematic Review and Meta-Analysis

,
,
,
,
and
1
Department of Pediatric Surgery, Hamad Medical Corporation, Doha 3050, Qatar
2
Pediatric Surgery Department, Fattouma Bourguiba University Hospital, Monastir 5000, Tunisia
3
Faculty of Medicine of Monastir, University of Monastir, Monastir 5000, Tunisia
4
Imam Abdulrahman Bin Faisal, Ministry of National Guard Health Affairs, Dammam 22490, Saudi Arabia
This article belongs to the Section Medical Research

Abstract

Background: Gastrointestinal surgery in children and neonates carries high risks of postoperative infections, inflammation, and delayed recovery. Probiotics may help restore gut microbial balance and improve clinical outcomes. This study systematically evaluates the effects of probiotic supplementation on postoperative outcomes in pediatric and neonatal gastrointestinal surgery. Methods: A systematic review and meta-analysis was conducted following Cochrane and PRISMA guidelines. PubMed, Scopus, Cochrane, and Web of Science were searched for randomized controlled trials (RCTs) and observational studies comparing probiotics with placebo, standard care, or surgery alone in children and neonates. Meta-analyses were performed using R programming, with pooled effect estimates reported alongside 95% confidence intervals (CI) and corresponding p-values. Results: Eight studies (6 RCTs and two cohorts) with 437 patients were included. Probiotics significantly reduced postoperative infections (risk ratio = 0.49, 95% CI: 0.26–0.92, p = 0.027) and C-reactive protein elevation (risk ratio = 0.42, 95% CI: 0.26–0.68, p < 0.001) and increased Bifidobacterium abundance (standardized mean difference = 0.84, 95% CI: 0.51–1.17, p < 0.001). No significant effect was seen on hospital length of stay or Lactobacillus concentrations. Qualitative synthesis indicated improvements in bowel function, immune markers, and growth in selected neonatal populations. Conclusions: Probiotics, particularly Bifidobacterium species, may reduce postoperative infections and inflammation in pediatric gastrointestinal surgery; however, the evidence is based on a limited number of studies and small pooled analyses, and larger well-designed trials are needed to confirm these findings.

1. Introduction

Gastrointestinal surgery in children and neonates is particularly challenging, not only because operating on small and developing bodies is technically demanding, but also because it places significant stress on their bodies [1,2]. Postoperative complications, including infections [3], inflammation [4], and delayed recovery [5], are major concerns that can prolong hospital stay, increase healthcare costs, and, most importantly, affect the well-being of vulnerable pediatric patients [6]. While advances in surgical techniques, anesthesia, and perioperative care have improved outcomes, managing the delicate balance of the gut environment remains an underexplored yet critical aspect of recovery [7].
The human gut hosts a complex microbial ecosystem that functions almost like an organ in itself, influencing digestion, immune function, and even systemic inflammatory responses [8]. In children and neonates, this microbial community is still developing and thus particularly sensitive to disturbances [9]. Surgical stress, anesthesia, perioperative antibiotics, and temporary fasting can all disrupt the gut microbiota, creating a state of imbalance known as dysbiosis [10]. Dysbiosis can increase susceptibility to infections, impair nutrient absorption, and exacerbate systemic inflammatory responses, making recovery more complicated [11]. Emerging evidence suggests that interventions aimed at supporting the gut microbiota could decrease these risks and improve clinical outcomes [12].
Postoperative complications remain a significant concern in pediatric gastrointestinal surgery. Global cohort studies report surgical site infection (SSI) rates ranging from 6.3% in high-income settings to 24.7% in low-income settings [13], highlighting a substantial burden of postoperative morbidity in children undergoing gastrointestinal procedures. Large population-based analyses have shown that postoperative complications occur in thousands of pediatric gastrointestinal surgical hospitalizations and are associated with prolonged hospital stays and increased healthcare costs [14].
Probiotics, live microorganisms that provide health benefits when given in adequate amounts, have attracted interest for restoring gut balance and supporting postoperative recovery [15]. They can inhibit harmful bacteria, produce antimicrobial compounds, strengthen the intestinal barrier, and modulate the immune system [16]. While these effects are well-studied in adults, children and neonates differ in gut microbiota, immune development, metabolism, and surgical responses, raising questions about whether adult findings apply to younger populations [9].
However, current pediatric probiotic studies remain limited by small sample sizes, heterogeneous surgical populations, inconsistent findings across outcomes, and a lack of standardized probiotic strains, dosing regimens, and timing of administration, which complicates interpretation and clinical translation. Some studies in pediatric surgical settings suggest probiotics can reduce infections, lower inflammation, and improve bowel function [17,18,19]. Given the growing recognition of the gut microbiota’s role in recovery, a systematic review of probiotics in this population is timely. This study evaluates the effects of probiotic supplementation on postoperative outcomes in children and neonates undergoing gastrointestinal surgery, aiming to clarify benefits, limitations, and gaps to guide clinical practice and future research.

2. Materials and Methods

This meta-analysis was performed following the methodological standards outlined in the Cochrane Handbook for Systematic Reviews of Interventions and is reported in line with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [20,21]. The protocol was registered in PROSPERO (CRD420251208620).

2.1. Search Strategy

A systematic literature search was conducted across PubMed, Scopus, Cochrane, and Web of Science to identify studies evaluating the effects of probiotics in pediatric and neonatal patients undergoing gastrointestinal surgery. Search terms included combinations of “probiotics,” “Lactobacillus,” “Bifidobacterium,” “neonate,” “child,” “gastrointestinal surgery,” and related keywords. The search was limited to English-language articles published from inception to October 2025. Reference lists of relevant studies and reviews were also screened to identify additional eligible studies. The detailed search strategy is shown in Table S1.

2.2. Eligibility Criteria

Studies were considered eligible if they included neonates or children undergoing gastrointestinal surgery and investigated any probiotic supplementation, such as Lactobacillus or Bifidobacterium species, compared with placebo, standard care, or surgery alone. Outcomes of interest included postoperative infections, hospital length of stay, C-reactive protein (CRP) elevation, changes in gut microbiota, bowel function, and other clinically relevant postoperative measures. Both randomized controlled trials (RCTs) and observational studies were included. Studies were excluded if they were review articles, editorials, animal studies, or non-English publications.

2.3. Study Selection

All retrieved records were imported into EndNote version 20, and duplicates were removed. Titles and abstracts were screened for relevance, followed by full-text assessment for eligibility. Discrepancies were resolved through discussion between two independent reviewers.

2.4. Data Extraction

Data were extracted by two reviewers using a standardized form, including study characteristics (country, study design), participant demographics (age, sex, weight), surgical indication, probiotic type and regimen, timing and duration of administration, and outcomes of interest. Any disagreements were resolved by consensus.

2.5. Risk of Bias Assessment

The quality of included RCTs was assessed using the revised Cochrane Risk of Bias tool (ROB 2), which evaluates five domains: randomization, deviations from intended interventions, outcome measurement, missing data, and selective reporting [22]. Each domain was rated as low, high, or some concerns, and an overall risk of bias judgment was assigned to each study.
Retrospective cohort studies were appraised using the Newcastle–Ottawa Scale (NOS), which assesses study quality based on three key components: selection of participants, comparability of cohorts, and ascertainment of outcomes. Stars are awarded for each item within these domains to reflect methodological strength, with higher scores indicating lower risk of bias [23].
The quality of evidence for main outcomes was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

2.6. Quantitative Synthesis

For outcomes reported in two or more studies, meta-analyses were performed using fixed-effects models for homogeneous data and random-effects models for heterogeneous data. Dichotomous outcomes were expressed as risk ratios (RR), while continuous outcomes were analyzed using mean differences or standardized mean differences (SMD). Heterogeneity was evaluated using both Cochran’s Q test and the I2 statistic, with a Q test p-value > 0.1 indicating homogeneity and the I2 value quantifying the extent of heterogeneity. When heterogeneity was present, random-effects models and sensitivity analyses were applied to explore potential sources; if heterogeneity remained unexplained, it was reported as unresolved. Pooled effect estimates are presented with 95% confidence intervals (CI) and corresponding p-values. All statistical analyses were performed using R programming.
Subgroup analyses were conducted based on timing of probiotic initiation, defined as early (within 1–3 days post-surgery) and delayed (approximately 5–10 days post-surgery), as well as by patient age group (older children vs. neonates), to evaluate differences in postoperative infection outcomes. Publication bias for postoperative infection outcomes was assessed visually using a funnel plot.

2.7. Qualitative Synthesis

For outcomes that could not be included in a meta-analysis, a descriptive synthesis was conducted to summarize key findings, including effects on gut microbiota composition, immune markers, defecation function, postoperative complications, and growth outcomes.

3. Results

Our search retrieved 4907 records from PubMed (1575), Scopus (1691), Cochrane (323), and Web of Science (1318). After removing 2543 duplicates, 2364 records were screened by title and abstract, excluding 2329 as irrelevant. Thirty-five full-text reports were assessed for eligibility, with exclusions made for review articles (7), editorial comments (1), non-English articles (4), animal studies (4), differing intervention timing (5), and non-GIT surgeries (6). Finally, eight studies met all criteria and were included in the systematic review synthesis [17,18,19,24,25,26,27,28] (Figure 1).
Figure 1. PRISMA flow diagram of study selection.

3.1. Baseline and Summary of the Included Studies

Across the eight included studies comprising 437 children and neonates from China, the USA, Japan, Poland, Australia, and Bangladesh, six were RCTs [18,19,25,26,27,28] and two were retrospective cohort studies [17,24]. Probiotic interventions most commonly included Lactobacillus rhamnosus and various Bifidobacterium species, administered either preoperatively or with the initiation of first oral feeds, for durations ranging from 5 to 180 days, depending on the surgical context and study objectives. Surgical indications encompassed appendectomy for complicated appendicitis, postoperative management of Hirschsprung disease following the Soave procedure, biliary atresia after Kasai portoenterostomy, gastroschisis repair, intestinal atresias, and mixed congenital anomalies among NICU populations (Table 1).
Table 1. Summary of the included studies.
Baseline characteristics were generally comparable between probiotic and control groups across studies, with similar distributions in age, sex, and weight. The average age among pediatric participants ranged from approximately 30 to 126 months, while neonates were enrolled between 0.06 and 3.09 months of age. Further details are shown in Table 2.
Table 2. Baseline characteristics of the included studies.

3.2. Quality Assessment

The risk of bias assessment indicated that all included RCTs, except Rao et al. (2022), exhibited a low risk across all evaluated domains. Rao et al. (2022) showed a high risk of bias, specifically in the domain of missing outcome data [28] (Figure 2).
Figure 2. Risk of bias assessment of included RCTs (ROB 2).
Regarding the included cohort studies, both demonstrated good overall quality, showing adequate selection, comparability, and outcome assessment [17,24] (Table S2).
The certainty of evidence for this meta-analysis ranged from high to very low according to the GRADE framework. Clinical outcomes derived from randomized controlled trials, including postoperative infection rates and hospital length of stay, were classified as high certainty with no serious risks of bias, inconsistency, or imprecision. In contrast, laboratory-based outcomes were rated as very low certainty. This is explained by the inclusion of non-randomized studies and by serious inconsistency, characterized by substantial statistical heterogeneity and discrepancies in microbiological measurement units across included studies (Table S3).

3.3. Quantitative Synthesis

3.3.1. Postoperative Infections

The pooled analysis of five studies (n = 156 probiotic; n = 153 control) yielded a risk ratio of 0.49 (95% CI: 0.26 to 0.92; p = 0.027), indicating a significant reduction in postoperative infections among patients receiving probiotics, with no heterogeneity (I2 = 0%; p = 0.93). Notably, Powell et al. (2016) reported zero events in both groups (Figure 3A).
Figure 3. (A) Effect of probiotics on postoperative infections, (B) effect of probiotics on hospital length of stay, and (C) effect of probiotics on C-reactive protein (CRP) elevation.
The funnel plot for postoperative infections appeared broadly symmetrical, suggesting no clear evidence of publication bias (Figure S1).
Subgroup analyses for postoperative infection outcomes showed that early initiation of probiotics resulted in an RR of 0.30 (95% CI: 0.06–1.44), while delayed initiation showed an RR of 0.54 (95% CI: 0.26–1.13), with no significant subgroup difference (p = 0.515). Age-based subgroup analysis demonstrated an RR of 0.42 (95% CI: 0.19–0.95) in older children and 0.64 (95% CI: 0.24–1.74) in neonates, with no significant subgroup difference (p = 0.528). Overall heterogeneity was low (I2 = 0%). Sensitivity analysis by study design, excluding the cohort study (Cheng 2023), showed no significant difference (RR = 0.56; 95% CI: 0.28–1.10; p = 0.094) (Figures S2–S4).

3.3.2. Hospital Length of Stay

The pooled analysis of three studies (n = 95 probiotic; n = 83 control) showed no significant reduction in hospital stay with probiotics (mean difference −0.20 days; 95% CI: −1.31 to 0.91; p = 0.723), with moderate heterogeneity across studies (I2 = 41%; p = 0.18) (Figure 3B).

3.3.3. C-Reactive Protein (CRP) Elevation

Analysis of two studies (n = 48 probiotic; n = 42 control) demonstrated a reduction in postoperative CRP elevation with probiotics (RR = 0.42; 95% CI: 0.26 to 0.68; p < 0.001), but unresolvable heterogeneity was observed (I2 = 71.7%; p = 0.06) (Figure 3C).

3.3.4. Lactobacillus and Bifidobacterium Concentration

Analysis of two studies examining changes in Lactobacillus concentrations showed an insignificant effect compared to control (SMD = 0.48; 95% CI: –1.27 to 2.24; p = 0.589), with unresolvable heterogeneity (I2 = 94.5%; p < 0.001) (Figure 4A).
Figure 4. (A) Effect of probiotics on Lactobacillus concentrations, and (B) effect of probiotics on Bifidobacterium concentrations.
In contrast, pooling two studies for Bifidobacterium concentrations demonstrated a substantial increase with probiotics (SMD = 0.84; 95% CI: 0.51 to 1.17; p < 0.001), with minimal heterogeneity (I2 = 0%; p = 0.64) (Figure 4B).

3.4. Qualitative Synthesis

3.4.1. Probiotics and Postoperative Outcomes

Probiotics showed several benefits in neonates and children undergoing gastrointestinal surgery. In neonates receiving Bifidobacterium breve, cow’s milk protein intolerance was significantly lower (6% vs. 67%), intestinal flora was improved, and immune maturation was supported [17]. In children under five, probiotics did not reduce surgical site infections or postoperative fever but indicated reduced systemic inflammation, while total white blood cell and neutrophil counts remained unchanged [25].
In children with Hirschsprung disease undergoing the Soave procedure, combined Bifidobacterium and Lactobacillus supplementation significantly improved defecation function, with an excellent Krickenbeck score rate of 96.97% versus 85% in controls [24].

3.4.2. Gut Dysbiosis and Growth

Neonates with congenital gastrointestinal surgical conditions receiving a three-strain bifidobacterial probiotic had reduced pathogenic bacterial abundance, increased Bifidobacteriaceae, higher stool short-chain fatty acid levels, and less postnatal head growth restriction, suggesting potential neurodevelopmental benefits. No probiotic-related infections occurred [28].

3.4.3. Microbiota Changes in Urgent Surgery

In neonates receiving Bifidobacterium animalis LKM512, surgery altered intestinal microbiota irrespective of probiotics. Probiotic use did not clearly enhance beneficial bacteria or clinical outcomes such as weight gain or infection prevention, emphasizing the need for further research on optimal timing and dosing [26].

3.4.4. Antibiotic-Associated Diarrhea

Among pediatric patients undergoing appendectomy for complicated appendicitis, Lactobacillus rhamnosus GG did not notably affect diarrhea incidence, though diarrhea peaked earlier in the probiotic group [18]. No adverse events were reported. Figure 5 shows a flowchart for the mechanistic approach.
Figure 5. Probiotics as a strategy to mitigate postoperative inflammation, barrier dysfunction, and complications.

4. Discussion

Our meta-analysis reveals that probiotic supplementation significantly reduces postoperative infections in children and neonates undergoing gastrointestinal surgery, cutting the risk by approximately 51%. This protective effect appeared consistently across the studies we examined, giving us confidence in the finding. We also found that probiotics significantly reduced C-reactive protein elevation, a marker that tells us how much inflammation is occurring in the body. Interestingly, Bifidobacterium bacteria increased significantly in children receiving probiotics, while Lactobacillus changes were less consistent. However, probiotics did not shorten hospital stays, suggesting that while they help prevent certain complications, they do not accelerate overall recovery time. The reduction in C-reactive protein and changes in microbiota, including increased Bifidobacterium, were based on only two studies and should therefore be interpreted cautiously as exploratory findings. Subgroup analyses suggested a consistent reduction in postoperative infections with probiotics across both initiation timing and age groups.
These findings align with the known physiological effects of surgery on the gastrointestinal tract. Surgical interventions disrupt intestinal microbial homeostasis through multiple mechanisms, including mucosal injury, perioperative antibiotic exposure, altered intestinal perfusion, and temporary cessation of enteral feeding [29]. Such disturbances favor the overgrowth of pathogenic microorganisms, increasing the risk of infection [30]. Probiotic supplementation may decrease these effects by competitively inhibiting pathogen colonization, producing antimicrobial metabolites, enhancing epithelial barrier integrity, and modulating immune responses to attenuate postoperative inflammation [31,32]. The observed reduction in C-reactive protein likely reflects this immunomodulatory action, suggesting that probiotics influence host inflammatory pathways rather than alleviating clinical symptoms [16].
The beneficial role of Bifidobacterium species warrants particular attention. These commensal bacteria predominate in the intestinal microbiota of infants and exhibit strong adhesion to the intestinal mucosa of young children [33]. Through the production of short-chain fatty acids, Bifidobacterium supports epithelial cell nutrition, reinforces mucosal barrier function, and creates an environment unfavorable to pathogenic bacterial proliferation [34].
Our findings are generally consistent with previous research on probiotics in surgical patients, though key differences emerge. Kasatpibal et al. (2017) conducted a network meta-analysis of 2952 adults undergoing elective surgery and found that synbiotics most effectively reduced surgical site infections, pneumonia, sepsis, hospital stay, and antibiotic use [35]. While their results showed overall reductions in postoperative complications, our pediatric-focused analysis demonstrated a greater 51% reduction in infections. This may reflect that children’s developing gut microbiota respond more readily to probiotic modulation than the more stable microbial communities in adults [36].
Similarly, Yang et al. (2017) reported that probiotics and synbiotics reduced infectious complications and shortened hospital stay by 3.2 days in adults after gastrointestinal surgery [37]. More recent meta-analyses in colorectal cancer surgery have similarly reported that probiotics reduce infections but show minimal or no effect on hospital length of stay [38]. Our analysis found no significant reduction in hospital stay, suggesting that pediatric discharge decisions depend on broader clinical and social factors beyond infection control [39].
Goldenberg et al. (2017) reported a reduction in Clostridioides difficile–associated diarrhea among patients receiving probiotics with antibiotics, but their cohort excluded surgical patients [40]. This larger effect may indicate that surgical stress, anesthesia, altered gut perfusion, and feeding interruptions limit probiotic efficacy postoperatively [41].
Recent evidence further supports the potential role of probiotics in improving postoperative outcomes. Updated systematic reviews and umbrella meta-analyses have reported that perioperative probiotics or synbiotics can reduce postoperative infections and other complications across various gastrointestinal surgeries, likely through modulation of gut microbiota and immune responses [42]. Similarly, Wu et al. (2025) reported that perioperative probiotics were associated with reduced postoperative infections and improved gut microbiota balance; however, most included studies involved adult surgical populations, highlighting the limited pediatric evidence [43].
Probiotics may exert beneficial effects through several molecular pathways. Lactobacillus and Bifidobacterium species can inhibit pathogenic bacteria via production of bacteriocins, lactic acid, and other antimicrobial metabolites [31,32]. They also enhance intestinal barrier function by regulating tight junction proteins and reducing epithelial permeability [32]. In addition, probiotics modulate host immune responses through pathways such as NF-κB signaling, promoting anti-inflammatory cytokine production while suppressing pro-inflammatory mediators [16,31]. These mechanisms may contribute to reduced postoperative inflammation and infection risk following gastrointestinal surgery. These mechanisms may be particularly relevant in neonates, whose immune systems and gut microbiota are still developing. NICU-related factors such as antibiotics and parenteral nutrition can further disrupt microbial balance. Although no probiotic-related infections were reported in the included studies, safety considerations remain important in vulnerable neonatal populations.
Our findings have important practical implications. The significant reduction in postoperative infections suggests that probiotics could become part of routine care for children undergoing gastrointestinal surgery, particularly in hospitals or regions where infection rates are high [44]. Probiotics are inexpensive and widely available, and our review found them to be safe, with no probiotic-related infections reported in any of the included studies [45]. These characteristics make them attractive for widespread use. However, the lack of impact on hospital length of stay reminds us that probiotics address only one aspect of recovery. Doctors should view them as an addition to—not a replacement for—careful surgical technique, appropriate antibiotic use, and comprehensive postoperative care [46]. The reduction in inflammatory markers we observed hints at benefits that might extend beyond infection prevention, potentially including reduced scar tissue formation, better wound healing, and improved long-term gut function [47], though these outcomes need dedicated research.

4.1. Strengths and Limitations of Our Study

Our study has several considerable strengths. It is the first systematic review to focus specifically on the effects of probiotics in pediatric and neonatal surgical populations, addressing an important gap in the literature. We followed well-established international standards for systematic reviews, conducted comprehensive searches across multiple major databases, and used a transparent, reproducible process with two independent reviewers at every stage. The methodological quality of included studies was formally assessed using established appraisal tools. Moreover, the consistent finding of reduced postoperative infections across different studies increases confidence in the reliability of this result.
However, several limitations should be acknowledged. First, only eight studies met our inclusion criteria, and several pooled analyses were based on only two or three studies, which limits the robustness of the estimates and makes the results more sensitive to the influence of individual studies. Second, substantial heterogeneity existed across studies in probiotic strains, dosages, timing, duration of administration, patient age groups, and surgical procedures—including appendectomy, Hirschsprung disease surgery, biliary atresia repair, and surgeries for congenital gastrointestinal anomalies—which differ in complexity and baseline infection risk, limiting the ability to draw precise clinical recommendations or attribute outcomes solely to probiotics. Another limitation is the difficulty in establishing causality due to variability in study designs and the lack of long-term longitudinal and large interventional studies. Finally, most studies originated from a limited number of countries, and only English-language publications were included, introducing a potential language bias.

4.2. Conclusions

This meta-analysis suggests that probiotics may help reduce postoperative infections and inflammation in children and neonates undergoing gastrointestinal surgery, indicating potential value as part of perioperative care. The evidence appears more consistent for Bifidobacterium species.
However, these findings should be interpreted cautiously because the evidence is derived from a small number of studies with limited pooled data. Further large, well-designed multicenter trials are needed to confirm these effects and clarify the optimal strains, timing, dosage, and duration of probiotic use.

4.3. Recommendations

Future research should focus on large, multi-center studies that compare specific probiotic formulations in clearly defined groups of surgical patients, measure outcomes using standardized methods, and follow patients long-term to assess growth, development, and quality of life. Advanced genetic techniques for studying gut bacteria could help identify which patients are most likely to benefit from probiotics. Until better evidence becomes available, probiotics should be considered as a low-risk addition to standard care in pediatric gastrointestinal surgery, especially when infection risk is high, while maintaining realistic expectations about overall impact on recovery.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/life16040569/s1, Table S1: Search strategy for each database; Table S2: Quality assessment of Cohort studies with the NOS tool; Table S3: GRADE assessment for main outcomes; Figure S1: Funnel plot for postoperative infection outcome; Figure S2: Subgroup analysis for postoperative infection outcome according to the timing of probiotic initiation; Figure S3: Subgroup analysis for postoperative infection outcome according to the age group; Figure S4: Sensitivity analysis for postoperative infection outcome according to study design.

Author Contributions

Conceptualization, A.N.A. and M.M.; methodology, software, and formal analysis, A.N.A. and M.S.Z.; validation, M.B.F. and A.K.; investigation, M.M. and S.K.; data curation, M.M., S.K., M.B.F. and A.K.; writing—original draft preparation, A.N.A. and M.S.Z.; writing—review and editing, M.M., S.K., M.B.F. and A.K.; project administration and supervision, A.N.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

No new data were created in this study.

Acknowledgments

The APC of this article was funded by Hamad Medical Corporation’s Medical Research Center (MRC).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Decembrino, N.; Scuderi, M.G.; Betta, P.M.; Leonardi, R.; Bartolone, A.; Marsiglia, R.; Marangelo, C.; Pane, S.; De Rose, D.U.; Salvatori, G.; et al. Microbiota-Modulating Strategies in Neonates Undergoing Surgery for Congenital Gastrointestinal Conditions: A Narrative Review. Nutrients 2025, 17, 2234. [Google Scholar] [CrossRef] [Scilit]
  2. Tzeng, T.H.; Nayak, S.P.; Huff, K.A. Nutritional Considerations in Neonates Requiring Gastrointestinal Surgery. Neoreviews 2025, 26, e172–e185. [Google Scholar] [CrossRef] [Scilit]
  3. Bhattacharyya, N.; Kosloske, A.M. Postoperative wound infection in pediatric surgical patients: A study of 676 infants and children. J. Pediatr. Surg. 1990, 25, 125–129. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Zhang, J.G.; Li, H.W.; Wu, X.M.; Yu, H.B.; Liu, Y.H.; Qi, L.; Bai, Y.; Yang, L.; Zhang, H.L.; Wang, X.Y.; et al. The impact of enhanced recovery after surgery on inflammatory indicators and prognosis related to complex appendicitis in children. Front. Pediatr. 2023, 11, 1261191. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Misal, U.S.; Joshi, S.A.; Shaikh, M.M. Delayed recovery from anesthesia: A postgraduate educational review. Anesth. Essays Res. 2016, 10, 164–172. [Google Scholar] [CrossRef] [Scilit]
  6. Wray, J.; Ridout, D.; Jones, A.; Davis, P.; Wellman, P.; Rodrigues, W.; Hudson, E.; Tsang, V.; Pagel, C.; Brown, K.L. Morbidities After Cardiac Surgery: Impact on Children’s Quality of Life and Parents’ Mental Health. Ann. Thorac. Surg. 2021, 112, 2055–2062. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Martínez-Ortega, A.; Piñar-Gutierrez, A.; Serrano Aguayo, P.; González-Navarro, I.; Remón-Ruíz, P.; Pereira, J.; García-Luna, P. Perioperative Nutritional Support: A Review of Current Literature. Nutrients 2022, 14, 1601. [Google Scholar] [CrossRef] [Scilit]
  8. Ma, Z.; Zuo, T.; Frey, N.; Rangrez, A.Y. A systematic framework for understanding the microbiome in human health and disease: From basic principles to clinical translation. Signal Transduct. Target. Ther. 2024, 9, 237. [Google Scholar] [CrossRef] [Scilit]
  9. Ronan, V.; Yeasin, R.; Claud, E.C. Childhood Development and the Microbiome—The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development. Gastroenterology 2021, 160, 495–506. [Google Scholar] [CrossRef] [Scilit]
  10. Ma, T.; Xue, X.; Tian, H.; Zhou, X.; Wang, J.; Zhao, Z.; Wang, M.; Song, J.; Feng, R.; Li, L.; et al. Effect of the gut microbiota and their metabolites on postoperative intestinal motility and its underlying mechanisms. J. Transl. Med. 2023, 21, 349. [Google Scholar] [CrossRef] [Scilit]
  11. Shen, Y.; Fan, N.; Ma, S.X.; Cheng, X.; Yang, X.; Wang, G. Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy. MedComm 2025, 6, e70168. [Google Scholar] [CrossRef] [Scilit]
  12. Goldiș, A.; Dragomir, R.; Mercioni, M.A.; Goldiș, C.; Sirca, D.; Enătescu, I.; Olariu, L.; Belei, O. Personalized Microbiome Modulation to Improve Clinical Outcomes in Pediatric Inflammatory Bowel Disease: A Multi-Omics and Interventional Approach. Microorganisms 2025, 13, 1047. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. GlobalSurg Collaborative. Surgical site infection after gastrointestinal surgery in children: An international, multicentre, prospective cohort study. BMJ Glob. Health 2020, 5. [Google Scholar]
  14. Brock, R.; Chu, A.; Lu, S.; Brindle, M.E.; Somayaji, R. Postoperative complications after gastrointestinal pediatric surgical procedures: Outcomes and socio-demographic risk factors. BMC Pediatr. 2022, 22, 358. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Yan, F.; Polk, D.B. Probiotics and Probiotic-Derived Functional Factors—Mechanistic Insights Into Applications for Intestinal Homeostasis. Front. Immunol. 2020, 11, 1428. [Google Scholar] [CrossRef] [Scilit]
  16. Mazziotta, C.; Tognon, M.; Martini, F.; Torreggiani, E.; Rotondo, J.C. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells 2023, 12, 184. [Google Scholar] [CrossRef] [Scilit]
  17. Ezaki, S.; Itoh, K.; Kunikata, T.; Suzuki, K.; Sobajima, H.; Tamura, M. Prophylactic probiotics reduce cow’s milk protein intolerance in neonates after small intestine surgery and antibiotic treatment presenting symptoms that mimics postoperative infection. Allergol. Int. 2012, 61, 107–113. [Google Scholar] [CrossRef] [Scilit]
  18. Garcia, M.G.; Dutton, H.; Cochrum, B.; Chen, P. Probiotics and Antibiotic-Associated Diarrhea in Pediatric Complicated Appendicitis. J. Pediatr. Surg. Nurs. 2023, 12, 126–134. [Google Scholar] [CrossRef] [Scilit]
  19. Orlowska, E.; Czubkowski, P.; Wolochowska, K.; Jarzebicka, D.; Motyl, I.; Socha, P. Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia—Randomized placebo controlled trial. Clin. Res. Hepatol. Gastroenterol. 2021, 45, 101753. [Google Scholar] [CrossRef] [Scilit]
  20. Cumpston, M.; Li, T.; Page, M.J.; Chandler, J.; Welch, V.A.; Higgins, J.P.T.; Thomas, J. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019, 10, Ed000142. [Google Scholar] [CrossRef] [Scilit]
  21. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009, 62, e1–e34. [Google Scholar] [CrossRef] [Scilit]
  22. Sterne, J.A.C.; Savović, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.; Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019, 366, l4898. [Google Scholar] [CrossRef] [Scilit]
  23. Wells, G.A.; Shea, B.; O’Connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ott. Hosp. Res. Inst. 2014. [Google Scholar]
  24. Cheng, T.; Yao, Y.; Zhang, S.; Hou, C. Effect of live combined Bifidobacterium and Lactobacillus tablets combined with Soave radical operation on postoperative intestinal flora and immune function in children with Hirschsprung disease. Am. J. Transl. Res. 2023, 15, 3572–3578. [Google Scholar] [PubMed]
  25. Enayet, S.M.S.; Hasina, K.; Tablu, A.H. Probiotics as Prophylaxis for Postoperative Infections of Under-five Children Following Gastrointestinal Surgery. J. Indian Assoc. Pediatr. Surg. 2022, 27, 528–533. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  26. Murakami, H.; Shimomura, Y.; Matsumoto, M.; Lane, G.J.; Yamataka, A.; Okawada, M. Intestinal microbiota in neonates requiring urgent surgery: Assessing the role of probiotics using fecal DNA sequencing. Pediatr. Surg. Int. 2016, 32, 37–43. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  27. Powell, W.T.; Borghese, R.A.; Kalanetra, K.M.; Mirmiran, M.; Mills, D.A.; Underwood, M.A. Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial. J. Pediatr. Gastroenterol. Nutr. 2016, 62, 852–857. [Google Scholar] [CrossRef] [Scilit]
  28. Rao, S.; Esvaran, M.; Chen, L.; Keil, A.D.; Gollow, I.; Simmer, K.; Wemheuer, B.; Conway, P.; Patole, S. Probiotic supplementation in neonates with congenital gastrointestinal surgical conditions: A pilot randomised controlled trial. Pediatr. Res. 2022, 92, 1122–1131. [Google Scholar] [CrossRef] [Scilit]
  29. Tsigalou, C.; Paraschaki, A.; Bragazzi, N.L.; Aftzoglou, K.; Bezirtzoglou, E.; Tsakris, Z.; Vradelis, S.; Stavropoulou, E. Alterations of gut microbiome following gastrointestinal surgical procedures and their potential complications. Front. Cell. Infect. Microbiol. 2023, 13, 1191126. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  30. Pickard, J.M.; Zeng, M.Y.; Caruso, R.; Núñez, G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 2017, 279, 70–89. [Google Scholar] [CrossRef] [Scilit]
  31. Raheem, A.; Liang, L.; Zhang, G.; Cui, S. Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation. Front. Immunol. 2021, 12, 616713. [Google Scholar] [CrossRef] [Scilit]
  32. Plaza-Diaz, J.; Ruiz-Ojeda, F.J.; Gil-Campos, M.; Gil, A. Mechanisms of Action of Probiotics. Adv. Nutr. 2019, 10, S49–S66. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  33. Tannock, G.W.; Lawley, B.; Munro, K.; Gowri Pathmanathan, S.; Zhou, S.J.; Makrides, M.; Gibson, R.A.; Sullivan, T.; Prosser, C.G.; Lowry, D.; et al. Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk. Appl. Environ. Microbiol. 2013, 79, 3040–3048. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  34. Morrison, D.J.; Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7, 189–200. [Google Scholar] [CrossRef] [Scilit]
  35. Kasatpibal, N.; Whitney, J.D.; Saokaew, S.; Kengkla, K.; Heitkemper, M.M.; Apisarnthanarak, A. Effectiveness of Probiotic, Prebiotic, and Synbiotic Therapies in Reducing Postoperative Complications: A Systematic Review and Network Meta-analysis. Clin. Infect. Dis. 2017, 64, S153–S160. [Google Scholar] [CrossRef] [Scilit]
  36. Rodríguez, J.M.; Murphy, K.; Stanton, C.; Ross, R.P.; Kober, O.I.; Juge, N.; Avershina, E.; Rudi, K.; Narbad, A.; Jenmalm, M.C.; et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microbes. Ecol. Health Dis. 2015, 26, 26050. [Google Scholar] [CrossRef] [Scilit]
  37. Yang, Z.; Wu, Q.; Liu, Y.; Fan, D. Effect of Perioperative Probiotics and Synbiotics on Postoperative Infections After Gastrointestinal Surgery: A Systematic Review With Meta-Analysis. J. Parenter. Enter. Nutr. 2017, 41, 1051–1062. [Google Scholar] [CrossRef] [Scilit]
  38. An, S.; Kim, K.; Kim, M.H.; Jung, J.H.; Kim, Y. Perioperative Probiotics Application for Preventing Postoperative Complications in Patients with Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicina 2022, 58, 1644. [Google Scholar] [CrossRef] [Scilit]
  39. Glick, A.F.; Farkas, J.S.; Magro, J.; Shah, A.V.; Taye, M.; Zavodovsky, V.; Rodriguez, R.H.; Modi, A.C.; Dreyer, B.P.; Famiglietti, H.; et al. Management of Discharge Instructions for Children With Medical Complexity: A Systematic Review. Pediatrics 2023, 152, e2023061572. [Google Scholar] [CrossRef] [Scilit]
  40. Goldenberg, J.Z.; Ma, S.S.; Saxton, J.D.; Martzen, M.R.; Vandvik, P.O.; Thorlund, K.; Guyatt, G.H.; Johnston, B.C. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev. 2013, Cd006095. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  41. Lian, X.; Zhu, Q.; Sun, L.; Cheng, Y. Effect of Anesthesia/Surgery on Gut Microbiota and Fecal Metabolites and Their Relationship With Cognitive Dysfunction. Front. Syst. Neurosci. 2021, 15, 655695. [Google Scholar] [CrossRef] [Scilit]
  42. Gao, S.; Liao, X.; He, Y.; Yang, J. Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: An umbrella review. Front. Microbiol. 2025, 16, 1635409. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  43. Wu, H.; Guan, Z.; Zhang, K.; Zhou, L.; Cao, L.; Mou, X.; Cui, W.; Tian, B.; Zhang, G. The effect of perioperative probiotics and synbiotics on postoperative infections in patients undergoing major liver surgery: A meta-analysis of randomized controlled trials. PeerJ 2025, 13, e18874. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  44. Suez, J.; Zmora, N.; Segal, E.; Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 2019, 25, 716–729. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  45. Amara, A.A.; Shibl, A. Role of Probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm. J. 2015, 23, 107–114. [Google Scholar] [CrossRef] [Scilit]
  46. Ruiz, N.I.; Herrera Giron, C.G.; Arragan Lezama, C.A.; Frias Redroban, S.J.; Ventura Herrera, M.O.; Sanic Coj, G.A. Timing and Protocols for Microbiome Intervention in Surgical Patients: A Literature Review of Current Evidence. Cureus 2025, 17, e86104. [Google Scholar] [CrossRef] [Scilit]
  47. Ambrose, L.; Dinu, C.A.; Gurau, G.; Maftei, N.M.; Matei, M.N.; Hincu, M.A.; Radu, M.; Mehedinti, M.C. The Role of Probiotics in Healing Burns and Skin Wounds; An Integrative Approach in the Context of Regenerative Medicine. Life 2025, 15, 1434. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.